Pure Global
NCT06297694

Clinical Interpretation and Cutoff Scores for ABILHAND Questionnaire in Rheumatoid Arthritis

Clinical Interpretation and Cutoff Scores for Manual Ability Measured by the ABILHAND Questionnaire in Individuals With Rheumatoid Arthritis
Pamukkale University·ClinicalTrials.govNot yet recruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Rheumatoid Arthritis
Study type
Observational
Sponsor & location
Primary sponsor
Pamukkale University
Timeline & enrollment
Phase
N/A
Start date
Mar 01, 2024
End date
Jul 01, 2024
Enrollment
156 participants
Primary outcome

Disease Activity Score (DAS 28),Nine hole peg test,Hand grip strength

Summary

In individuals with rheumatoid arthritis, the most significant symptom is the loss of manual
 ability and function in the hands. In rheumatoid arthritis, where patient-reported assessment
 scales are frequently used, hand skills should be evaluated with an ideal questionnaire that
 best represents hand activities. The ABILHAND-RA questionnaire possesses all these features,
 being a short and easily fillable survey. The aim is to determine of clinically significant
 cutoff scores for perceived manual ability evaluated by ABILHAND corresponding to observed
 and perceived upper extremity assessments in individuals with rheumatoid arthritis.

ICD-10 classifications
Rheumatoid arthritis, unspecifiedOther rheumatoid arthritisOther specified rheumatoid arthritisRheumatoid arthritis with involvement of other organs and systemsSeronegative rheumatoid arthritis
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06297694
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06297694 through Pure Global AI's free database. This phase not specified trial is sponsored by Pamukkale University and is currently Not yet recruiting. The study focuses on Rheumatoid Arthritis. Target enrollment is 156 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.